Form 4: Replimune CCO Sells Shares for Tax Obligations

Replimune Group's Chief Commercial Officer, Christopher Sarchi, sold 5,208 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Christopher Sarchi, Chief Commercial Officer of Replimune Group, Inc. (REPL), sold 5,208 shares of common stock.
• The transaction occurred on November 17, 2025, at a weighted average price of $9.1 per share, with prices ranging from $8.88 to $9.26.
• The sale was non-discretionary and executed to cover tax withholding obligations associated with the partial vesting of his Restricted Stock Units (RSUs).
• Following this transaction, Mr. Sarchi beneficially owns 123,088 shares of Replimune Group, Inc. common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax obligations related to RSU vesting. It is a neutral event, neither significantly positive nor negative for the company's operational or financial outlook.

Positives

• The sale indicates the vesting of Restricted Stock Units (RSUs) for the Chief Commercial Officer, which is a positive for employee compensation and retention.

Negatives

• A reduction in direct beneficial ownership by a key officer, although for tax purposes, represents a decrease in their direct stake.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to equity compensation and tax obligations, common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal impact as it's a routine, non-discretionary sale for tax purposes, not indicative of a change in management's confidence or company fundamentals.
• Employees: The vesting of RSUs is a positive for the Chief Commercial Officer, reflecting earned compensation.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary "sell to cover" transaction by a Chief Commercial Officer to satisfy tax obligations upon RSU vesting. Such transactions are common and pre-planned, and do not typically signal a change in the company's fundamental outlook or management's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance remains appropriate based solely on this filing.

Keywords

Replimune Group, REPL, Christopher Sarchi, Chief Commercial Officer, Form 4, Insider Trading, Stock Sale, RSU Vesting, Tax Withholding, Equity Compensation